Drugs for Hematology
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Hematology Drugs Market Research Report 2023
1 Hematology Drugs Market Overview
1.1 Product Overview and Scope of Hematology Drugs
1.2 Hematology Drugs Segment by Type
1.2.1 Global Hematology Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Hematology Drugs Segment by Application
1.3.1 Global Hematology Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Hematology Drugs Market Size Estimates and Forecasts
1.4.1 Global Hematology Drugs Revenue 2017-2028
1.4.2 Global Hematology Drugs Sales 2017-2028
1.4.3 Hematology Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Hematology Drugs Market Competition by Manufacturers
2.1 Global Hematology Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Hematology Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Hematology Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Hematology Drugs Manufacturing Sites, Area Served, Product Type
2.5 Hematology Drugs Market Competitive Situation and Trends
2.5.1 Hematology Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hematology Drugs Players Market Share by Revenue
2.5.3 Global Hematology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hematology Drugs Retrospective Market Scenario by Region
3.1 Global Hematology Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Hematology Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Hematology Drugs Market Facts & Figures by Country
3.3.1 North America Hematology Drugs Sales by Country
3.3.2 North America Hematology Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Hematology Drugs Market Facts & Figures by Country
3.4.1 Europe Hematology Drugs Sales by Country
3.4.2 Europe Hematology Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hematology Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Hematology Drugs Sales by Region
3.5.2 Asia Pacific Hematology Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Hematology Drugs Market Facts & Figures by Country
3.6.1 Latin America Hematology Drugs Sales by Country
3.6.2 Latin America Hematology Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hematology Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Hematology Drugs Sales by Country
3.7.2 Middle East and Africa Hematology Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hematology Drugs Historic Market Analysis by Type
4.1 Global Hematology Drugs Sales Market Share by Type (2017-2022)
4.2 Global Hematology Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Hematology Drugs Price by Type (2017-2022)
5 Global Hematology Drugs Historic Market Analysis by Application
5.1 Global Hematology Drugs Sales Market Share by Application (2017-2022)
5.2 Global Hematology Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Hematology Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Celgene Hematology Drugs Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Hematology Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Hematology Drugs Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Sanof
6.4.1 Sanof Corporation Information
6.4.2 Sanof Description and Business Overview
6.4.3 Sanof Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanof Hematology Drugs Product Portfolio
6.4.5 Sanof Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bristol-Myers Squibb Hematology Drugs Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 AbbVie Hematology Drugs Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Hematology Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 GSK
6.8.1 GSK Corporation Information
6.8.2 GSK Description and Business Overview
6.8.3 GSK Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 GSK Hematology Drugs Product Portfolio
6.8.5 GSK Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Johnson & Johnson Hematology Drugs Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Hematology Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Takeda Hematology Drugs Product Portfolio
6.10.5 Takeda Recent Developments/Updates
7 Hematology Drugs Manufacturing Cost Analysis
7.1 Hematology Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hematology Drugs
7.4 Hematology Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hematology Drugs Distributors List
8.3 Hematology Drugs Customers
9 Hematology Drugs Market Dynamics
9.1 Hematology Drugs Industry Trends
9.2 Hematology Drugs Market Drivers
9.3 Hematology Drugs Market Challenges
9.4 Hematology Drugs Market Restraints
10 Global Market Forecast
10.1 Hematology Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hematology Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Hematology Drugs by Type (2023-2028)
10.2 Hematology Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hematology Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Hematology Drugs by Application (2023-2028)
10.3 Hematology Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hematology Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Hematology Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hematology Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Hematology Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Hematology Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Hematology Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Hematology Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Hematology Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hematology Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Hematology Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Hematology Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Hematology Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Hematology Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hematology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematology Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hematology Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Hematology Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Hematology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Hematology Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Hematology Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Hematology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Hematology Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Hematology Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Hematology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Hematology Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Hematology Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Hematology Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Hematology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Hematology Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Hematology Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Hematology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Hematology Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Hematology Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Hematology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Hematology Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Hematology Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Hematology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Hematology Drugs Revenue Share by Type (2017-2022)
Table 43. Global Hematology Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Hematology Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Hematology Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Hematology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Hematology Drugs Revenue Share by Application (2017-2022)
Table 48. Global Hematology Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Celgene Corporation Information
Table 50. Celgene Description and Business Overview
Table 51. Celgene Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Celgene Hematology Drugs Product
Table 53. Celgene Recent Developments/Updates
Table 54. Pfizer Corporation Information
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Pfizer Hematology Drugs Product
Table 58. Pfizer Recent Developments/Updates
Table 59. Roche Corporation Information
Table 60. Roche Description and Business Overview
Table 61. Roche Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Roche Hematology Drugs Product
Table 63. Roche Recent Developments/Updates
Table 64. Sanof Corporation Information
Table 65. Sanof Description and Business Overview
Table 66. Sanof Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Sanof Hematology Drugs Product
Table 68. Sanof Recent Developments/Updates
Table 69. Bristol-Myers Squibb Corporation Information
Table 70. Bristol-Myers Squibb Description and Business Overview
Table 71. Bristol-Myers Squibb Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Bristol-Myers Squibb Hematology Drugs Product
Table 73. Bristol-Myers Squibb Recent Developments/Updates
Table 74. AbbVie Corporation Information
Table 75. AbbVie Description and Business Overview
Table 76. AbbVie Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. AbbVie Hematology Drugs Product
Table 78. AbbVie Recent Developments/Updates
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Business Overview
Table 81. Novartis Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Novartis Hematology Drugs Product
Table 83. Novartis Recent Developments/Updates
Table 84. GSK Corporation Information
Table 85. GSK Description and Business Overview
Table 86. GSK Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. GSK Hematology Drugs Product
Table 88. GSK Recent Developments/Updates
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Business Overview
Table 91. Johnson & Johnson Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Johnson & Johnson Hematology Drugs Product
Table 93. Johnson & Johnson Recent Developments/Updates
Table 94. Takeda Corporation Information
Table 95. Takeda Description and Business Overview
Table 96. Takeda Hematology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Takeda Hematology Drugs Product
Table 98. Takeda Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Hematology Drugs Distributors List
Table 102. Hematology Drugs Customers List
Table 103. Hematology Drugs Market Trends
Table 104. Hematology Drugs Market Drivers
Table 105. Hematology Drugs Market Challenges
Table 106. Hematology Drugs Market Restraints
Table 107. Global Hematology Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Hematology Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Hematology Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Hematology Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Hematology Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Hematology Drugs Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Hematology Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Hematology Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Hematology Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Hematology Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Hematology Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Hematology Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hematology Drugs
Figure 2. Global Hematology Drugs Market Share by Type in 2021 & 2028
Figure 3. OTC Product Picture
Figure 4. Rx Drugs Product Picture
Figure 5. Global Hematology Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Other
Figure 9. Global Hematology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Hematology Drugs Market Size (2017-2028) & (US$ Million)
Figure 11. Global Hematology Drugs Sales (2017-2028) & (K Units)
Figure 12. Hematology Drugs Sales Share by Manufacturers in 2021
Figure 13. Global Hematology Drugs Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Hematology Drugs Players: Market Share by Revenue in 2021
Figure 15. Hematology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Hematology Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Hematology Drugs Sales Market Share by Region in 2021
Figure 18. Global Hematology Drugs Revenue Market Share by Region (2017-2022)
Figure 19. Global Hematology Drugs Revenue Market Share by Region in 2021
Figure 20. the United States Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. UK Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Hematology Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Hematology Drugs by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Hematology Drugs
Figure 44. Manufacturing Process Analysis of Hematology Drugs
Figure 45. Hematology Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celgene Pfizer Roche Sanof Bristol-Myers Squibb AbbVie Novartis GSK Johnson & Johnson Takeda